Want to see GB:GNIP full AI Analyst Report?
GenIP Plc (GNIP) AI Stock Analysis
GenIP Plc
(LSE:GNIP)
The overall score is low primarily because the company combines rapid revenue growth with extremely weak profitability, heavy and worsening cash burn, and shrinking equity, creating a highly fragile financial profile that dominates the assessment. The technical picture adds further pressure, as the stock is in a persistent downtrend with negative momentum, even if oversold conditions may allow for intermittent bounces. Valuation contributes modestly to the score, as negative earnings and the absence of a dividend make the investment case largely speculative rather than supported by conventional valuation metrics.
GenIP Plc (GNIP) vs. iShares MSCI United Kingdom ETF (EWC)
- Market Cap
- GBP 475.53K
- Dividend Yield
- ā
- Average Volume (3M)
- 42.65K
- Price to Earnings (P/E)
- -0.5
- Beta (1Y)
- 1.30
- Revenue Growth
- ā
- EPS Growth
- ā
- Country
- UK
- Employees
- 2
- Sector
- General
- Sector Strength
- 55
- Industry
- Specialty Business Services
GenIP Plc Business Overview & Revenue Model
Company Description
GenIP Plc specializes in developing pioneering generative artificial intelligence solutions. The company was founded on February 23, 2024, and its primary operations are situated in London, United Kingdom.
GenIP Plc Financial Statement Overview
Summary
Financial performance is very weak despite rapid revenue growth: gross margin has improved, but operating and net losses are extremely large relative to revenue, equity is being eroded by accumulated losses, and cash burn is substantial and worsening, leaving the company in a fragile, early-stage, high-risk financial position.
Income Statement
20Very NegativeBalance Sheet
35NegativeCash Flow
18Very Negative| Breakdown | TTM | Dec 2025 | Dec 2024 |
|---|---|---|---|
Income Statement | |||
| Total Revenue | 0 | 520.39K | 123.02K |
| Gross Profit | 0 | 164.74K | 15.16K |
| EBITDA | -93.41K | -1.16M | -832.54K |
| Net Income | -93.56K | -1.25M | -886.83K |
Balance Sheet | |||
| Total Assets | 307.59K | 1.05M | 1.63M |
| Cash, Cash Equivalents and Short-Term Investments | 0 | 660.99K | 972.36K |
| Total Debt | 72.14K | 0 | 133.57K |
| Total Liabilities | 145.66K | 470.42K | 359.74K |
| Stockholders Equity | 161.93K | 579.16K | 1.27M |
Cash Flow | |||
| Free Cash Flow | -71.98K | -736.00K | -683.04K |
| Operating Cash Flow | -69.91K | -720.31K | -556.74K |
| Investing Cash Flow | -2,071 | -6,074 | -124.49K |
| Financing Cash Flow | 71.98K | 415.01K | 1.65M |
GenIP Plc Peers Comparison
Overall Rating
GB:IGP78Outperform
GB:CLBS54Neutral
GB:GBG54Neutral
GB:PULS43Neutral- GB:GNIP42.5Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| GB:IGP | 78Outperform | GBP 85.42M | 24.73 | 18.91% | ā | -3.15% | -17.89% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| GB:CLBS | 54Neutral | GBP 19.42M | -59.54 | -1.32% | 0.07% | -41.95% | -106.40% |
| GB:GBG | 54Neutral | GBP 366.83M | -4.98 | -14.39% | 2.74% | 0.82% | -997.08% |
| GB:PULS | 43Neutral | GBP 20.00M | -2.63 | -21.57% | ā | 4.57% | -3.85% |
| GB:GNIP | 43Neutral | GBP 676.21K | -0.51 | -135.15% | ā | ā | ā |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GB:GNIP | GenIP Plc | 2.65 | -22.35 | -89.40% | |
| GB:PULS | Access Intelligence | 14.75 | -20.25 | -57.86% | |
| GB:CLBS | Celebrus Technologies Plc | 52.00 | -86.37 | -62.42% | |
| GB:GBG | GB Group plc | 163.80 | -65.67 | -28.62% | |
| GB:IGP | Intercede Group plc | 138.50 | -8.00 | -5.46% |
GenIP Plc Corporate Events
GenIP Deepens Global Footprint as Losses Widen on Early-Stage Investment
PositiveGenIP reported unaudited interim results for the first half of 2026 showing modest revenue of $53,000, a 6% gross margin and an adjusted EBITDA loss of $692,000, with $410,000 in cash at period end, as the company continues to invest heavily from an...
GenIP Secures New Global Contracts and Expands AI-Driven Innovation Services
PositiveGenIP Plc has secured a series of new and recurring contracts worth a total of $87,000 across Chile, the UK and North America, driven primarily by demand for its Invention Evaluator reports from leading research universities. The company has deepened...
GenIP Steps Up Global Expansion as AIāDriven SaaS Platform Nears Launch
PositiveGenIP has outlined its next phase of growth following the CEO’s recent visit to the U.K. for its AGM and a series of meetings with clients, investors and strategic partners. The company hosted an AI‑focused roundtable with leaders from ac...
GenIP Wins Strong Shareholder Backing at AGM, Securing Mandates for Growth
PositiveGenIP Plc said all resolutions at its annual general meeting were passed, including approval of its annual report, reappointment of auditor HW Fisher LLP, and the re-election of key board members such as Lord David Willetts, Melissa Cruz, Kevin Fitzp...
GenIP strengthens AI-led tech transfer position with high-level UK roundtable
PositiveGenIP Plc has underlined its role in AI-driven technology transfer by hosting a closed-door senior roundtable with Knowledge Exchange UK, attended by more than twenty high-level figures from universities, government, research agencies and internation...
GenIP Updates Total Voting Rights and Share Capital Structure
NeutralGenIP Plc has confirmed that its total issued share capital consists of 25,517,461 ordinary shares of £0.00425 each, all carrying voting rights, and that it holds no shares in treasury. This updated share capital figure provides investors with a...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 29, 2026